Read news as it happens
Create a Rediffmail account
Get Rediff News delivered into your Inbox daily
Bansal pay issue: Kiran Mazumdar-Shaw appeals for a closure
The settlement with Sebi was seen as Infosys admitting guilt of the lapse, clearing out any legal or regulatory...
Cancer, heart condition drugs to get cheaper following price cap
According to highly placed sources in NPPA, the reduction in prices following the latest exercise will range between...
Pharma sector in alarm over govt's cure
The government plans to rationalise trade margins for many other medical devices, besides stents and knee implants.
'It was very hard to build an R&D set-up in India'
Sohini Das chats with MD of Zydus Cadila Healthcare Pankaj R Patel & his son Sharvil Patel.
Infy seeks Sebi help over Bansal's Rs 17.38 cr severance pay
Analysts say IT major cleaning up act before new CEO takes over; regulator might take a year
Why India is key to Philips' transformation
India serves as the company's R&D hub as it morphs into a health tech major.
Sayre Therapeutics: In the business of cancer
Sayre Therapeutics aims for a spot among top 5 players in oncology.
How desi brothers built a $1.8 bn drug co
Amneal Pharmaceuticals is set to pip Sun Pharma as the fifth largest generics maker in the US, reports Sohini Das.
After 15 years, Ranjit Shahani steps down as Novartis' India chief
The face of MNC drug firms in India and champion of IPR protection, he oversaw the Swiss giant's India expansion, its...
Why GSK is changing its strategy after 93 years
Increased price control over branded generic medicines has affected its profitability
Office email App
© 2017 Rediff.com